Webinars

  • Years
  • Topics
  • Communities

Showing 24 of 67 results

Jeanette Schulz-Menger
Jeanette Schulz-Menger
Massimo Imazio
Massimo Imazio
Olivier Goumet
Olivier Goumet
Vanessa Christian
Vanessa Christian

Wednesday, 28 October 2026 | 18:00 CET

Myocarditis and pericarditis: understanding the ESC Guidelines

Thomas Gorter
Thomas Gorter
Luke Howard
Luke Howard
Cornelia Margineanu
Cornelia Margineanu
Mardi Gomberg-Maitland
Mardi Gomberg-Maitland

Monday, 19 October 2026 | 18:00 CET

HFA Journal Club: sotatercept for combined post- and precapillary pulmonary hypertension associated with heart failure

Charlotte Manisty
Charlotte Manisty
Mathew Maurer
Mathew Maurer
Brett Sperry
Brett Sperry
Daniela Tomasoni
Daniela Tomasoni

Monday, 5 October 2026 | 18:00 CET

Amyloidosis : Treatment sequencing and patient selection in the era of multiple ATTR therapies

Martha Grogan
Martha Grogan
Theresa McDonagh
Theresa McDonagh
Marianna Fontana
Marianna Fontana
Michelle Kittleson
Michelle Kittleson

Monday, 28 September 2026 | 18:00 CET

Amyloidosis : clinical trial evidence across therapeutic classes in ATTR-CM

Marianna Adamo
Marianna Adamo
Ee Ling Heng
Ee Ling Heng
Marco Metra
Marco Metra

Tuesday, 22 September 2026 | 18:00 CET

Contemporary management of atrioventricular disease in patients with heart failure

Esther Gonzalez Lopez
Esther Gonzalez Lopez
Marianna Fontana
Marianna Fontana
Caroline Morbach
Caroline Morbach
Michelle Kittleson
Michelle Kittleson

Monday, 7 September 2026 | 18:00 CET

Amyloidosis : from protein misfolding to therapy - stabilizers, silencers, antibodies, and gene editing in ATTR

Sebastian Zimmer
Sebastian Zimmer
Augustin Coisne
Augustin Coisne
Denisa Muraru
Denisa Muraru

Wednesday, 1 July 2026 | 18:00 CET

Delivering early access to innovation in structural heart disease intervention

Michael A Borger
Michael A Borger
Tanja Katharina Rudolph
Tanja Katharina Rudolph
Marta Sitges
Marta Sitges

Tuesday, 16 June 2026 | 18:00 CET

Valvular heart disease: life-time management, finding the balance between durability and repeat intervention

Alaide Chieffo
Alaide Chieffo
Derk Frank
Derk Frank
Fabien Praz
Fabien Praz

Friday, 5 June 2026 | 18:00 CET

From trials to guidelines in structural heart disease: translating evidence into daily practice and managing capacity

Ana Garcia-Alvarez
Ana Garcia-Alvarez
Marinela Chaparro Munoz
Marinela Chaparro Munoz
Jordi Baneras
Jordi Baneras

Friday, 24 April 2026 | 18:00 CET

From TAPSE to tissue characterisation: a stepwise approach to right ventricular imaging

Marco Zuin
Marco Zuin
Julie Helms
Julie Helms
Ibtihal Al Amri
Ibtihal Al Amri
Erik Klok
Erik Klok
Gregory Piazza
Gregory Piazza

Thursday, 19 February 2026 | 18:00 CET

Treatment of severe PE: state of the art

George Lazaros
George Lazaros
Massimo Imazio
Massimo Imazio
Jan Wolfgang Groeschel
Jan Wolfgang Groeschel

Wednesday, 26 November 2025 | 18:00 CET

Myocarditis and pericarditis: what every cardiologist must know about therapy

Jeanette Schulz-Menger
Jeanette Schulz-Menger
Valentino Collini
Valentino Collini
Bettina Heidecker
Bettina Heidecker

Wednesday, 19 November 2025 | 18:00 CET

Myocarditis and pericarditis: what every cardiologist must know about diagnosis

Eva Prescott
Eva Prescott
Borja Ibanez
Borja Ibanez
Dan Atar
Dan Atar

Monday, 17 November 2025 | 18:00 CET

Are beta-blockers still indicated after myocardial infarction?

Francesco Saia
Francesco Saia
Philippe Genereux
Philippe Genereux
Julia Grapsa
Julia Grapsa

Wednesday, 30 July 2025 | 17:00 CET

Timely treatment of asymptomatic patients with aortic stenosis: insights from the EARLY TAVR trial

Carsten Tschoepe
Carsten Tschoepe
Dia Smiley
Dia Smiley
Francesco Cappelli
Francesco Cappelli
Marianna Fontana
Marianna Fontana

Wednesday, 16 July 2025 | 18:00 CET

New drugs in the treatment of amyloidosis

Pablo Garcia-Pavia
Pablo Garcia-Pavia
Victoria Delgado
Victoria Delgado
Thibaud Damy
Thibaud Damy
Marco Merlo
Marco Merlo

Monday, 7 July 2025 | 18:00 CET

When to suspect and how to diagnose cardiac amyloidosis (multimodality imaging)

Eric Durand
Eric Durand
Gemma Mccalmont
Gemma Mccalmont
Stephen Little
Stephen Little
Bettina Hoejberg Kirk
Bettina Hoejberg Kirk

Tuesday, 4 February 2025 | 18:00 CET

Optimising TAVI outcomes: the ideal valvular heart team structure and role of the valve coordinator

Alec Vahanian
Alec Vahanian
Philippe Pibarot
Philippe Pibarot
Marina Urena
Marina Urena
Maggie Simpson
Maggie Simpson

Monday, 2 December 2024 | 18:00 CET

Addressing undertreatment in aortic valve disease: bridging the gap for women and the elderly

Fabian Knebel
Fabian Knebel
Tim Lavin
Tim Lavin
Rocio Eiros
Rocio Eiros

Tuesday, 26 November 2024 | 18:00 CET

Alnylam Satellite Webinar: Navigating Cardiac Manifestations in hATTR Polyneuropathy: A Multisystemic Disease Perspective

Helene Eltchaninoff
Helene Eltchaninoff
Didier Tchetche
Didier Tchetche
Philippe Genereux
Philippe Genereux
Nicolas van Mieghem
Nicolas van Mieghem

Tuesday, 12 November 2024 | 18:00 CET

Unlocking the future of aortic care: clinical insights from trials and registries

Bernard David Prendergast
Bernard David Prendergast
Nina Ajmone Marsan
Nina Ajmone Marsan
Tanja Katharina Rudolph
Tanja Katharina Rudolph
Sandra Lauck
Sandra Lauck

Monday, 4 November 2024 | 18:00 CET

Spotlight on aortic stenosis: raising awareness to enhance detection and diagnosis

Iacopo Olivotto
Iacopo Olivotto
Juan Pablo Kaski
Juan Pablo Kaski
Sotiria Liori
Sotiria Liori
Antonio Cannata
Antonio Cannata

Wednesday, 23 October 2024 | 18:00 CET

The HFA Journal Club: the SEQUOIA-HCM trial

Philippe Pibarot
Philippe Pibarot
Konstantinos Toutouzas
Konstantinos Toutouzas
Nina Ajmone Marsan
Nina Ajmone Marsan
Julien Dreyfus
Julien Dreyfus

Wednesday, 26 June 2024 | 18:00 CET

How would you manage severe valvular lesions (aortic and tricuspid) in heart failure patients?

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources